- Investing Ideas
- U.S. Top Growth Stocks
U.S. Top Growth Stocks
Results
112
112 companies
Zevra Therapeutics
Market Cap: US$579.9m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$9.90
7D
-4.7%
1Y
36.9%
Travere Therapeutics
Market Cap: US$3.8b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$40.89
7D
5.4%
1Y
103.6%
Infinity Natural Resources
Market Cap: US$1.0b
Engages in the acquisition, exploration, and development of properties to produce crude oil, natural gas, and natural gas liquids in the United States.
INR
US$16.25
7D
3.6%
1Y
1.4%
Axsome Therapeutics
Market Cap: US$9.6b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
AXSM
US$185.06
7D
1.1%
1Y
68.4%
Madrigal Pharmaceuticals
Market Cap: US$11.9b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$516.69
7D
-2.1%
1Y
51.6%
NVIDIA
Market Cap: US$5.3t
Operates as a data center scale AI infrastructure company.
NVDA
US$213.07
7D
6.6%
1Y
95.4%
Syndax Pharmaceuticals
Market Cap: US$1.9b
A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.
SNDX
US$21.13
7D
-9.4%
1Y
54.2%
T1 Energy
Market Cap: US$1.5b
Provides energy solutions for solar modules and cells in the United States, Norway and internationally.
TE
US$4.90
7D
-3.7%
1Y
295.2%
Insmed
Market Cap: US$29.4b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$134.94
7D
-4.3%
1Y
89.0%
AppLovin
Market Cap: US$154.8b
Provides end-to-end artificial intelligence-powered advertising solutions for businesses in the United States and internationally.
APP
US$449.03
7D
-5.1%
1Y
55.4%
AnaptysBio
Market Cap: US$1.9b
A clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States.
ANAB
US$66.11
7D
27.6%
1Y
212.1%
Ardelyx
Market Cap: US$1.5b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$5.98
7D
0.3%
1Y
9.6%
Rhythm Pharmaceuticals
Market Cap: US$5.8b
A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United States and internationally.
RYTM
US$84.14
7D
-0.9%
1Y
29.0%
Inter & Co
Market Cap: US$3.5b
Through its subsidiaries, engages in the banking and spending, investments, insurance brokerage, and inter shop businesses in Brazil and the United States.
INTR
US$7.80
7D
-4.1%
1Y
18.9%
Alignment Healthcare
Market Cap: US$4.3b
Operates a consumer-centric healthcare platform for seniors in the United States.
ALHC
US$21.90
7D
1.6%
1Y
25.6%
TOYO
Market Cap: US$414.1m
Engages in the upstream production of wafer and silicon, midstream production of solar cell, downstream production of photovoltaic (PV) modules, and other stages of the solar power supply chain in Asia and the United States.
TOYO
US$10.84
7D
-20.9%
1Y
273.8%
Micron Technology
Market Cap: US$591.6b
Designs, develops, manufactures, and sells memory and storage products in the United States, Taiwan, Japan, Mainland China, Hong Kong, Europe, and internationally.
MU
US$504.26
7D
12.2%
1Y
555.9%
Caledonia Mining
Market Cap: US$469.9m
Primarily operates a gold mine in Jersey.
CMCL
US$22.85
7D
-6.2%
1Y
71.4%
Capricor Therapeutics
Market Cap: US$2.0b
A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.
CAPR
US$33.98
7D
-3.8%
1Y
170.5%
FirstSun Capital Bancorp
Market Cap: US$1.1b
Operates as the bank holding company for Sunflower Bank, National Association that provides commercial and consumer banking and financial services to small and medium-sized companies in the United States.
FSUN
US$37.31
7D
-2.1%
1Y
5.6%
Aldeyra Therapeutics
Market Cap: US$95.1m
A biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases.
ALDX
US$1.58
7D
-6.0%
1Y
-41.3%
Smith Micro Software
Market Cap: US$20.4m
Develops and sells software solutions to simplify and enhance the mobile experience to wireless and cable service providers in the Americas, Europe, the Middle East, and Africa.
SMSI
US$0.80
7D
9.7%
1Y
-20.9%
Pelthos Therapeutics
Market Cap: US$83.1m
A bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.
PTHS
US$24.97
7D
8.6%
1Y
95.1%
Pagaya Technologies
Market Cap: US$1.1b
A product-focused technology company, deploys data science and proprietary artificial intelligence-powered technology for financial services, their customers, and institutional or sophisticated investors in the United States, Israel, and the Cayman Islands.
PGY
US$13.48
7D
-5.9%
1Y
17.5%
ARS Pharmaceuticals
Market Cap: US$789.4m
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally.
SPRY
US$7.94
7D
1.3%
1Y
-43.0%
Gorilla Technology Group
Market Cap: US$356.7m
Provides solutions in security, network, business intelligence, and Internet of Things (IoT) technology in Taiwan and the United Kingdom.
GRRR
US$13.05
7D
-6.5%
1Y
-26.7%
Zscaler
Market Cap: US$21.6b
Operates as a cloud security company worldwide.
ZS
US$136.07
7D
-2.5%
1Y
-39.2%
Bank of Marin Bancorp
Market Cap: US$404.5m
Operates as the holding company for Bank of Marin that provides a range of financial services to small to medium-sized businesses, not-for-profit organizations, and commercial real estate investors in the United States.
BMRC
US$25.99
7D
0.4%
1Y
23.8%
Hesai Group
Market Cap: US$3.7b
Through with its subsidiaries, engages in the development, manufacture, and sale of three-dimensional light detection and ranging solutions (LiDAR) in Mainland China, Europe, North America, and internationally.
HSAI
US$22.48
7D
5.1%
1Y
23.5%
CVB Financial
Market Cap: US$2.8b
Operates as bank holding company for Citizens Business Bank, National Association, a state-chartered bank that provides banking and financial services to small to mid-sized businesses and individuals.
CVBF
US$20.49
7D
1.0%
1Y
9.1%
Laird Superfood
Market Cap: US$36.4m
Manufactures and markets plant-based natural and functional food in the United States.
LSF
US$3.17
7D
3.9%
1Y
-45.4%
Rayonier
Market Cap: US$6.5b
A land resources real estate investment trust (REIT) with a portfolio comprising over four million acres in the U.S.
RYN
US$21.47
7D
1.3%
1Y
-12.4%
HubSpot
Market Cap: US$11.9b
Provides a cloud-based customer relationship management (CRM) platform for businesses in the Americas, Europe, and the Asia Pacific.
HUBS
US$225.97
7D
-1.9%
1Y
-63.1%
Bitgo Holdings
Market Cap: US$1.2b
Operates as a digital asset infrastructure company in the United States and internationally.
BTGO
US$10.00
7D
-8.4%
1Y
n/a
Intapp
Market Cap: US$1.8b
Through its subsidiary, Integration Appliance, Inc., provides AI-powered solutions in the United States, the United Kingdom, and internationally.
INTA
US$22.69
7D
0.2%
1Y
-58.4%
Cineverse
Market Cap: US$52.8m
Operates as a streaming technology and entertainment company.
CNVS
US$2.51
7D
5.5%
1Y
-15.8%